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Abstract: A ring–ring transformation in the series of spiro[indole-
3,5′-pyrimido[4,5-b]quinoline]-2,2′,4′-trione derivatives prepared
by a three-component reaction of (thio)barbituric acids, electron-
rich aromatic amines, and isatins was observed. 
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The heterocyclic oxindole system containing one carbon
atom common to two rings is a widely distributed struc-
tural framework present in a number of pharmaceuticals
and natural products.1 The presence of the chiral spiro car-
bon leads to the sterically constrained spiro structure and
is one of the important factors of the biological activities.
Thus, the spirooxindole and spiroindoline ring systems
are present in a number of natural alkaloids, including an-
esthetics (horsfiline),2a mammalian cell cycle inhibitors
(spirotryprostatins A and B),2b and in synthetic drugs (for
instance, ibutamoren mesylate, an orally active nonpep-
tide growth hormone secretagogue3) (Figure 1).
On the other hand, the target scaffold includes so impor-
tant motifs such as 6-aminouracil and 1,4-dihydropyri-
dine. The latter are known to be calcium agonists and
calcium channel blockers (for example, nifedipine).4 6-(2-
Aminoethyl)amino-5-chlorouracil (AEAC), which be-
longs to a class of 6-aminouracils, is a thymidine phos-
phorylase inhibitor and exhibits antitumor activity5
(Figure 1). The combination of these moieties presents in-
triguing possibilities for pharmacological studies and
drug design. 
Multicomponent reactions (MCRs) as the synthetic ap-
proach to such scaffolds are very advantageous in many
aspects. Such reactions offer a wide range of possibilities
for the efficient construction of complex molecules in a
single procedural step and are perfectly amenable to auto-
mation for combinatorial synthesis. Because of their con-
vergence and productivity, the MCRs have attracted
considerable attention from the point of view of combina-
torial and medicinal chemistry and are particularly useful
for the preparation of spiro heterocyclic systems.6
Iaroshenko and co-workers6h have recently communicat-
ed a practical route to 7-azaindole framework by a one-
pot, three-component cyclocondensation of N-substituted
2-amino-4-cyanopyrroles, various aldehydes, and active
methylene compounds.
Continuing our research program7 on the efficient synthe-
sis of drug-like fused pyridines, we have undertaken at-
tempts in the context of special interest in the synthesis of
spiro heterocycles containing uracil, 1,4-dihydropyridine,
and indole ring fragments by a three-component reaction
of (thio)barbituric acids, aromatic amines, and isatins. We
now report that such compounds can be obtained under
mild reaction conditions in the presence of iodine. More-
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over, in the case of N-unsubstituted isatins, unexpected
recyclization of spiro[indole-3,5′-pyrimido[4,5-b]quino-
line]-2,2′,4′-trione derivatives was observed.
Recently, there have been many reports on the synthesis
of spiro[dihydropyridine-oxindole] compounds from isat-
ins, 2-naphthylamine, and 1,3-dicarbonyls8 as well as
from isatins, heterocyclic amines, and barbituric acids9
via the Hantzsch-like reaction in the presence of various
catalysts and under various conditions. However, to the
best of our knowledge, there are no literature data for the
preparation of spiroindolinone derivatives from isatins,
aromatic amines, and barbituric acids.10 
We report now on the formation of spiro[indole-3,5′-py-
rimido[4,5-b]quinoline]-2,2′,4′-triones from barbituric
and thiobarbituric acids, electron-rich anilines, and N-
substituted and N-unsubstituted isatins. Thus, four com-
mercially available barbituric acid derivatives 1, three
electron-rich anilines 2, and six isatins 3 were chosen for
the library validation.
In the initial study, we have developed the synthesis of the
hitherto unknown spiro heterocycles 4 starting from N-
methyl- and N-ethylisatins by a one-pot, three-component
reaction depicted in Scheme 1. Different catalysts and sol-
vents were first briefly examined and the best result was
obtained by using iodine as catalyst and EtOH as the sol-
vent.11 It was found that treatment of N-substituted isatins
with dimethylbarbituric or diethylthiobarbituric acids and
anilines (3,5-dimethoxy-, 3,4,5-trimethoxyanilines, 2-an-
thracenamine) in ethanol in the presence of a catalytic
amount of iodine (0.05 equiv) at room temperature result-
ed in the formation of expected spiroindolinones 4a–i in
moderate to high yields (47–86%). In most cases, the re-
action was complete after 24 hours and the products could
be isolated by simple filtration of the precipitate formed.
The progress of the reaction was monitored by TLC, and
the results are summarized in Table 1. It is important that
only electron-rich anilines 2 can effectively participate in
the reaction with 1 and 3, providing a variety of com-
pounds 4 with high purity. The regiochemistry of 4c and
4f was confirmed by 2D NOESY experiments. Spiroindo-
linones 4 are likely formed via initial condensation of isat-
ins 3 with barbituric acids 1 to afford the Knoevenagel
product A,12 which then undergoes in situ Michael addi-
tion with anilines 2 (these electron-rich compounds act as
C-nucleophiles) followed by the cyclocondensation of the
intermediate B to give the corresponding products 4
(Scheme 1).
To expand the scope of the present reaction, isatin and its
5-substituted derivatives were examined to replace N-
methyl- and N-ethylisatins. However, when the three-
component reaction of N-unsubstituted isatins, electron-
rich anilines and (thio)barbituric acids was conducted un-
der the same condition (ethanol, I2, r.t., 24 h), isomeric
spiro[indole-3,5′-pyrimido[4,5-b]quinoline]-2,2′,4′-trione
derivatives 5a–l were obtained in variable 26–91% yields
(Table 1). Their spectral data were similar but inconsistent
with the expected structure 4. Indeed, the data were in
good agreement with the structure of an unexpected prod-
uct 5, being constructed via ring-opening of N-unsubsti-
tuted spiroindolinone fragment followed by formation of
a dihydropyridine ring from intermediate C. Selected
NMR spectral data of isomers 4 and 5 (Figure 2) are sum-
marized in Tables 2–5. It should be also noted that singlets
for the dihydropyridine proton H-10′ in 4 and 5 appeared
at δ = 9.16–9.22 and 9.14–9.59, respectively. To confirm
the conclusion about the regiochemistry of 5, additional
2D NOESY experiment was carried out for 5c (see SI),
which exhibits strong cross-peaks between protons H-1
and H-7 as well as between H-10′ and H-9′, and H-10′ and
CH3-1′, indicating that they are spatially close to each oth-
er (Figure 3). Moreover, the structures of compounds 5b
(Figure 4) and 5f (Figure 5) were unambiguously con-
firmed by X-ray single crystal analysis. Recently, similar
transformation of the indolinone ring have been observed
in the reaction of 6-aminouracils with isatins.13 
Scheme 1 Synthesis of isomeric spiro[indole-3,5′-pyrimido[4,5-
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Figure 3  Determination of regioisomer 5c by 2D NOESY (for the
original 2D NOESY spectra, see the Supporting Information); arrows
show the decisive correlations
Table 1  Isomeric Spiro[indole-3,5′-pyrimido[4,5-b]quinoline]-2,2′,4′-triones 4a–k and 5a–n 
Barbituric acid 1 Aniline 2 Isatin 3 Products 4 and 5
R1 X R2 R3 R4 Isomer Yield (%)a
Me O 3,5-(MeO)2 H Me 4a 86
Me O 3,4,5-(MeO)3 H Me 4b 52
Me O 3,5-(MeO)2 H Et 4c 82
Me O 3,4,5-(MeO)3 H Et 4d 55
Et S 3,5-(MeO)2 H Me 4e 56
Et S 3,4,5-(MeO)3 H Me 4f 47
Et S 3,5-(MeO)2 H Et 4g 72
Et S 3,4,5-(MeO)3 H Et 4h 47
Et S 2-anthraceneamine H Et 4i 73
H O 3,5-(MeO)2 H H 5a 51
Me O 3,5-(MeO)2 H H 5b 57
Me O 3,5-(MeO)2 Cl H 5c 72
Me O 3,5-(MeO)2 F H 5d 75
Pr O 3,5-(MeO)2 H H 5e 79
Pr O 3,4,5-(MeO)3 H H 5f 26
Pr O 2-anthraceneamine H H 5g 91
Et S 3,5-(MeO)2 H H 5h 81
Et S 3,4,5-(MeO)3 H H 5i 53
Et S 3,5-(MeO)2 Cl H 5j 68
Et S 3,5-(MeO)2 F H 5k 59
Et S 3,4,5-(MeO)3 F H 5l 36
Me O 3,4,5-(MeO)3 NO2 H 4j + 5m (85:15) 67/23
b
Et S 3,5-(MeO)2 NO2 H 4k + 5n (25:75) 63/19
b
a Yields refer to pure isolated products.
b Yield of isolated mixture/yield of the major isomer isolated in a pure state.
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Table 2  The 1H and 13C NMR Data for Isomers 4 from 3,5-Dimethoxyaniline
Isomer 4 1H NMR, δ 13C NMR, δ
CH3O-6′ CH3O-8′ H-7′ H-9′ CH3O-6′ CH3O-8′ CH-7′ CH-9′
4a 3.36 3.77 6.12 6.67 56.8 56.1 95.5 95.0
4c 3.32 3.77 6.13 6.67 56.9 57.4 97.8 97.4
4e 3.38 3.78 6.15 6.79 56.9 56.2 96.0 95.2
4g 3.34 3.79 6.16 6.80
Table 3  The 1H and 13C NMR Data for Isomers 5 from 3,5-Dimethoxyaniline
Isomer 5 1H NMR, δ 13C NMR, δ
CH3O-4 CH3O-6 H-5 H-7 CH3O-4 CH3O-6 CH-5 CH-7
5b 3.50 3.76 6.04 6.12
5c 3.53 3.77 6.07 6.14 56.5 56.2 93.1 90.2
5d 3.52 3.77 6.07 6.13 56.5 56.2 93.1 90.2
5e 3.49 3.75 6.03 6.11 56.4 56.1 92.9 90.1
5h 3.51 3.76 6.05 6.13 56.5 56.2 93.1 90.2
5j 3.54 3.77 6.09 6.15 56.6 56.2 93.2 90.3
5k 3.53 3.77 6.08 6.15 56.5 56.2 93.2 90.3
5n 3.54 3.78 6.10 6.20 56.6 56.2 93.3 90.4
Table 4  The 1H and 13C NMR Data for Isomers 4 from 3,4,5-Trimethoxyaniline
Isomer 4 1H NMR, δ 13C NMR, δ
CH3O-6′ CH3O-7′ CH3O-8′ H-9′ CH3O-6′ CH3O-7′ CH3O-8′ CH-9′
4b 3.12 3.60 3.83 6.93 60.4 61.2 56.6 97.2
4d 3.03 3.60 3.83 6.92 60.1 61.1 56.6 97.2
4f 3.14 3.61 3.85 6.97 60.4 61.2 56.7 97.5
4h 3.04 3.61 3.85 7.05 60.2 61.1 56.7 97.5
4j 3.27 3.62 3.85 6.96 60.4 61.2 56.7 97.3
Table 5  The 1H and 13C NMR Data for Isomers 5 from 3,4,5-Trimethoxyaniline
Isomer 5 1H NMR, δ 13C NMR, δ
CH3O CH3O CH3O H-7 CH3O CH3O CH3O CH-7
5f 3.29 3.59 3.83 6.36 56.8 60.8 61.3 92.0
5i 3.28 3.59 3.83 6.38 56.9 60.8 61.4 92.1
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Figure 4  ORTEP plot of 4,6-dimethoxy-1′,3′-dimethyl-1′H-spi-
ro[indole-3,5′-pyrimido[4,5-b]quinoline]-2,2′,4′(1H,3′H,10′H)-tri-
one (5b) (thermal ellipsoids at 50% probability)
Figure 5  ORTEP plot of 4,5,6-trimethoxy-1′,3′-dipropyl-1′H-spi-
ro[indole-3,5′-pyrimido[4,5-b]quinoline]-2,2′,4′(1H,3′H,10′H)-tri-
one (5f) (thermal ellipsoids at 50% probability)
As can be seen from Table 1, the reaction described has
virtually no limitations as regards the length of the alkyl
substituent in the (thio)barbituric molecule, but requires
N-unsubstituted isatins. This result and the absence of the
isomeric products 4 seem to indicate that the N-unsubsti-
tuted isatin fragment facilitates the rearrangement of
intermediate A into B toward formation of the thermody-
namically favored amide bond in spiroindolinone moiety
5 (Scheme 1). Only in the case of 5-nitroisatin the mix-
tures 4j + 5m = 85:15 and 4k + 5n = 25:75 were obtained,
from which major isomers 4j and 5n were isolated in a
pure state (Table 1). 
Next, attempts were made to replace isatins by other ac-
tive carbonyl compounds, such as chloral hydrate and eth-
yl pyruvate. When chloral hydrate was subjected to an
analogous reaction, the unexpected product 6 with a hy-
drolyzed trichloromethyl group from the four-component
reaction was obtained under the same conditions in 17%
yield. Fused 1,4-dihydropyridine 7, prepared from ethyl
pyruvate in 25% yield, is an unstable product and rear-
ranges slowly at room temperature under the action of at-
mospheric moisture to give quantitatively indolinone 8
(Scheme 2). The structures of compounds 6–8 were char-
acterized by IR, 1H, 13C NMR spectral data as well as MS
and HRMS analyses. In addition, the structure of 8 is con-
firmed by X-ray diffraction analysis (Figure 6).14 
Figure 6  ORTEP plot of 5-(4,6-dimethoxy-3-methyl-2-oxo-2,3-di-
hydro-1H-indol-3-yl)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-tri-
one (8) (thermal ellipsoids at 50% probability)
Treatment of isatin with 3-benzylamino-5,5-dimethylcy-
clohex-2-enone resulted in the formation of 2-benzyl-4,4-
dimethyl-4,5-dihydropyrrolo[2,3,4-kl]acridin-1(2H)-one
(9) in 43% yield (Scheme 3). Very recently, this reaction
has been described for the three-component condensation
of isatin, dimedone, and various amines.15 
In conclusion, we have developed a novel and efficient
synthesis of spiroindolinones via a three-component reac-
tion between (thio)barbituric acids, electron-rich anilines,
and isatins. The described synthesis in ethanol media in
the presence of iodine is a simple, practical, and environ-
mentally friendly method for the preparation of heterocy-
clic compounds containing spiroindole-3,5′-
pyrimido[4,5-b]quinoline system, which undergoes an
unexpected recyclization related with the indolinone ring
opening in the case of N-unsubstituted isatins. On the oth-
er hand, the combinatorial aspect of the developed here
synthetic strategies can be used in the biology-oriented
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All solvents were purified and dried by standard methods. NMR
spectra were recorded on a Bruker AV 300 and Bruker AV 400. IR
spectra were recorded on a PerkinElmer FT IR 1600 spectrometer
(ATR). Mass spectra were obtained using a Hewlett-Packard HP
GC/MS 5890/5972 instrument (EI, 70 eV) by GC inlet or on a MX-
1321 instrument (EI, 70 eV) by direct inlet. Column chromatogra-
phy was performed on silica gel (63–200 mesh, Merck). Silica gel
Merck 60F254 plates were used for TLC analysis. Chemical yields
refer to pure isolated substances.
Spiro[indole-3,5′-pyrimido[4,5-b]quinoline]-2,2′,4′-triones 4 
and 5; General Procedure
Into a 25 mL flask were placed the corresponding barbituric acid 1
(1.92 mmol), isatin 3 (1.92 mmol), aromatic amine 2 (1.92 mmol),
and EtOH (6 mL). I2 (0.096 mmol, 0.05 equiv) was then added and
the mixture was stirred overnight at r.t. The next day, the precipitate
that had formed was collected by filtration, washed with EtOH
(2 × 3 mL), and recrystallized from an appropriate solvent, if neces-
sary.
6′,8′-Dimethoxy-1,1′,3′-trimethyl-1′H-spiro[indole-3,5′-pyrimi-
do[4,5-b]quinoline]-2,2′,4′ (1H,3′H,10′H)-trione (4a) 
Yield: 716 mg (86%); white solid; mp >320 °C. 
1H NMR (300.1 MHz, DMSO-d6): δ = 3.01 (s, 3 H, NCH3-3′), 3.20
(s, 3 H, NCH3-1), 3.36 (s, 3 H, CH3O-6′), 3.55 (s, 3 H, NCH3-1′),
3.77 (s, 3 H, CH3O-8′), 6.12 (d, 
4J = 2.6 Hz, 1 H, H-7′), 6.67 (d, 4J =
2.6 Hz, 1 H, H-9′), 6.77–6.85 (m, 1 H, H-5), 6.85 (d, 3J = 7.2 Hz, 1
H, H-4), 6.88 (d, 3J = 7.7 Hz, 1 H, H-7), 7.13–7.20 (m, 1 H, H-6),
9.17 (br s, 1 H, NH). 
13C NMR (62.9 MHz, DMSO-d6): δ = 27.1 (NCH3-1), 28.3 (NCH3-
3′), 31.1 (NCH3-1′), 49.6 (C-3,5′), 56.1 (CH3O-8′), 56.8 (CH3O-6′),
87.2 (C-4a′), 95.0 (CH-9′), 95.5 (CH-7′), 105.2, 107.4 (CHAr), 122.2
(CHAr), 123.7 (CHAr), 128.2 (CHAr), 136.8, 138.1, 145.6, 146.2,
151.2, 159.1, 160.1, 160.6, 179.8 (C=O-2). 
MS (EI, 70 eV): m/z (%) = 435 ([M + H]+, 14), 434 ([M]+, 59), 406
(18), 376 (34), 375 (100), 318 (11), 44 (16). 




pyrimido[4,5-b]quinoline]-2,2′,4′ (1H,3′H,10′H)-trione (5c) 
Yield: 627 mg (72%); white solid; mp >320 °C. 
1H NMR (300.1 MHz, DMSO-d6): δ = 3.08 (s, 3 H, NCH3-3′), 3.53
(s, 3 H, CH3O-4), 3.56 (s, 3 H, NCH3-1′), 3.77 (s, 3 H, CH3O-6),
6.07 (d, 4J = 2.1 Hz, 1 H, H-5), 6.14 (d, 4J = 2.1 Hz, 1 H, H-7), 6.59
(d, 4J = 2.5 Hz, 1 H, H-6′), 7.26 (dd, 3J = 8.7 Hz, 4J = 2.5 Hz, 1 H,
H-8′), 7.34 (d, 3J = 8.7 Hz, 1 H, H-9′), 9.45 (br s, 1 H, NH-10′),
10.45 (br s, 1 H, NH-1). 
13C NMR (75.5 MHz, DMSO-d6): δ = 28.3 (NCH3-3′), 31.0 (NCH3-
1′), 51.0 (C-3,5′), 56.2 (CH3O-6), 56.5 (CH3O-4), 84.6 (C-4a′), 90.2
(CH-7), 93.1 (CH-5), 117.3, 119.4 (CH-9′), 125.0 (C-5a′), 125.9
(CH-6′), 127.5, 128.7 (CH-8′), 135.9 (C-9a′), 143.7, 146.7, 151.3,
156.8, 160.3, 161.8, 181.3 (C=O-2). 
MS (GC, 70 eV): m/z (%) = 454 ([M]+, 35Cl, 35), 453 (27), 452
(100), 423 (14), 421 (39), 412 (21), 411 (15), 410 (57), 290 (19),
289 (10), 288 (51). 
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HRMS (ESI): m/z calcd for C22H20
35ClN4O5 [M + H]
+: 455.11167;
found: 455.11218. 
Supporting Information for this article is available online at
http://www.thieme-connect.com/ejournals/toc/synthesis. Included
are experimental procedures, characterization data, and 1H, 13C
NMR spectra of all compounds.Suporting IformatinSuporting Iformatin
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